New disease-modifying Alzheimer’s drugs work best when they are given to patients in the early stages of disease. The drug ...

Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after ...

Donanemab, given as an infusion every four weeks, has shown to slow down cognitive decline by 4-7 months in clinical studies.

While caffeine is often relied on to boost energy levels, it can lead to irritability, anxiety, and energy crashes. Experts ...

Female life expectancy in the most deprived areas of Scotland was 10.5 years lower than in the least deprived areas, the ...